Teladoc Health, Inc. (NYSE:TDOC) Given Consensus Rating of "Hold" by Brokerages

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) have been assigned a consensus recommendation of "Hold" from the nineteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Thirteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $12.44.

Several research analysts recently issued reports on the stock. Bank of America decreased their price target on shares of Teladoc Health from $16.50 to $13.50 and set a "neutral" rating for the company in a research note on Tuesday, May 14th. Canaccord Genuity Group lowered their target price on shares of Teladoc Health from $25.00 to $17.00 and set a "buy" rating for the company in a report on Thursday, August 1st. Piper Sandler cut their price target on Teladoc Health from $25.00 to $10.00 and set an "overweight" rating on the stock in a research note on Tuesday, August 6th. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research note on Thursday, August 1st. Finally, Barclays cut their target price on Teladoc Health from $20.00 to $10.00 and set an "overweight" rating on the stock in a research note on Thursday, August 1st.

Teladoc Health Trading Up 0.8 %

Shares of NYSE TDOC traded up $0.06 during trading hours on Friday, hitting $7.16. The company's stock had a trading volume of 8,648,213 shares, compared to its average volume of 5,486,465. The business has a 50-day simple moving average of $8.56 and a 200-day simple moving average of $11.99. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of -5.09 and a beta of 0.93. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $23.19.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.36) by $0.08. The business had revenue of $642.44 million for the quarter, compared to the consensus estimate of $649.34 million. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. On average, analysts anticipate that Teladoc Health will post -0.7 earnings per share for the current fiscal year.

Insider Activity

In related news, CMO Stephany Verstraete sold 15,000 shares of Teladoc Health stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $7.60, for a total value of $114,000.00. Following the completion of the sale, the chief marketing officer now owns 45,158 shares of the company's stock, valued at $343,200.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CMO Stephany Verstraete sold 15,000 shares of the stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $7.60, for a total value of $114,000.00. Following the transaction, the chief marketing officer now owns 45,158 shares in the company, valued at approximately $343,200.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Vidya Raman-Tangella sold 3,857 shares of the firm's stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the transaction, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. The disclosure for this sale can be found here. Insiders have sold 42,880 shares of company stock valued at $355,689 in the last ninety days. 0.95% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds have recently modified their holdings of the business. Parallel Advisors LLC increased its holdings in Teladoc Health by 14.6% in the 4th quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider's stock worth $87,000 after acquiring an additional 515 shares in the last quarter. M&T Bank Corp increased its stake in shares of Teladoc Health by 5.5% in the fourth quarter. M&T Bank Corp now owns 11,152 shares of the health services provider's stock worth $241,000 after purchasing an additional 584 shares in the last quarter. Van ECK Associates Corp increased its stake in shares of Teladoc Health by 20.3% in the fourth quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider's stock worth $77,000 after purchasing an additional 606 shares in the last quarter. Ignite Planners LLC raised its position in shares of Teladoc Health by 6.9% during the 1st quarter. Ignite Planners LLC now owns 13,307 shares of the health services provider's stock valued at $198,000 after purchasing an additional 857 shares during the period. Finally, Hexagon Capital Partners LLC lifted its stake in shares of Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider's stock valued at $34,000 after buying an additional 1,065 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.